Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Chrystyn

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Practice. Supplement|November 11, 2005
Do patients show the same level of adherence with all dry powder inhalers?H Chrystyn
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Validation of the use of Bayesian analysis in the optimization of gentamicin therapy from the commencement of dosingH Chrystyn
The Journal of Pharmacy and Pharmacology|May 1, 1997
Community care of asthma: the pharmacist as counsellor?H Chrystyn
Clinical Pharmacokinetics|January 1, 1994
Standards for bioequivalence of inhaled productsH Chrystyn
Respiratory Medicine|March 14, 2000
Is inhaled beclomethasone (BDP) with a non-CFC propellant equivalent to the CFC propellant formulations?H Chrystyn
British Journal of Clinical Pharmacology|June 10, 2000
Methods to determine lung distribution of inhaled drugs - could gamma scintigraphy be the gold standard?H Chrystyn
Respiratory Medicine|February 25, 1998
Is total particle dose more important than particle distribution?H Chrystyn
British Journal of Clinical Pharmacology|April 25, 2001
Methods to identify drug deposition in the lungs following inhalationH Chrystyn
Allergy|July 28, 1999
Anatomy and physiology in delivery: can we define our targets?H Chrystyn
Respiratory Medicine|February 18, 2003
Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these ratesH Chrystyn
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Practice. Supplement|November 11, 2005
Do patients show the same level of adherence with all dry powder inhalers?H Chrystyn
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Validation of the use of Bayesian analysis in the optimization of gentamicin therapy from the commencement of dosingH Chrystyn
The Journal of Pharmacy and Pharmacology|May 1, 1997
Community care of asthma: the pharmacist as counsellor?H Chrystyn
Clinical Pharmacokinetics|January 1, 1994
Standards for bioequivalence of inhaled productsH Chrystyn
Respiratory Medicine|March 14, 2000
Is inhaled beclomethasone (BDP) with a non-CFC propellant equivalent to the CFC propellant formulations?H Chrystyn
British Journal of Clinical Pharmacology|June 10, 2000
Methods to determine lung distribution of inhaled drugs - could gamma scintigraphy be the gold standard?H Chrystyn
Respiratory Medicine|February 25, 1998
Is total particle dose more important than particle distribution?H Chrystyn
British Journal of Clinical Pharmacology|April 25, 2001
Methods to identify drug deposition in the lungs following inhalationH Chrystyn
Allergy|July 28, 1999
Anatomy and physiology in delivery: can we define our targets?H Chrystyn
Respiratory Medicine|February 18, 2003
Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these ratesH Chrystyn
Pageof 8